These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3903736)

  • 1. Beta-Blocker Heart Attack Trial: impact of propranolol therapy on ventricular arrhythmias.
    Morganroth J; Lichstein E; Byington R
    Prev Med; 1985 May; 14(3):346-57. PubMed ID: 3903736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of propranolol on ventricular arrhythmia. The beta-blocker heart attack trial experience.
    Lichstein E; Morganroth J; Harrist R; Hubble E
    Circulation; 1983 Jun; 67(6 Pt 2):I5-10. PubMed ID: 6342839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of propranolol in patients with myocardial infarction and ventricular arrhythmia.
    Friedman LM; Byington RP; Capone RJ; Furberg CD; Goldstein S; Lichstein E
    J Am Coll Cardiol; 1986 Jan; 7(1):1-8. PubMed ID: 3510232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of prolonged ventricular repolarization following myocardial infarction: the BHAT experience. The BHAT Study Group.
    Peters RW; Byington RP; Barker A; Yusuf S
    J Clin Epidemiol; 1990; 43(2):167-72. PubMed ID: 2406377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of propanolol in patients entered in the Beta-Blocker Heart Attack Trial with their first myocardial infarction and persistent electrocardiographic ST-segment depression.
    Shivkumar K; Schultz L; Goldstein S; Gheorghiade M
    Am Heart J; 1998 Feb; 135(2 Pt 1):261-7. PubMed ID: 9489974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are 24 hours of ambulatory ECG monitoring necessary for a patient after infarction?
    Davis BR; Friedman LM; Lichstein E
    Am Heart J; 1988 Jan; 115(1 Pt 1):83-91. PubMed ID: 3276112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of the duration of the ambulatory electrocardiogram after myocardial infarction.
    Davis BR; Friedman LM; Lichstein E
    Med Decis Making; 1988; 8(1):9-18. PubMed ID: 3277008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of ventricular ectopic activity in survivors of acute myocardial infarction who receive propranolol.
    Kostis JB; Wilson AC; Sanders MR; Byington RP
    Am J Cardiol; 1988 May; 61(13):975-8. PubMed ID: 3284322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta blockade after myocardial infarction: the Norwegian propranolol study in high-risk patients.
    Hansteen V
    Circulation; 1983 Jun; 67(6 Pt 2):I57-60. PubMed ID: 6342841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of propranolol in non-Q-wave acute myocardial infarction in the beta blocker heart attack trial.
    Gheorghiade M; Schultz L; Tilley B; Kao W; Goldstein S
    Am J Cardiol; 1990 Jul; 66(2):129-33. PubMed ID: 2196771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Beta-Blocker Heart Attack Trial in perspective.
    Goldstein S
    Cardiology; 1983; 70(5):255-62. PubMed ID: 6141847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of ventricular ectopic activity in survivors of acute myocardial infarction.
    Kostis JB; Byington R; Friedman LM; Goldstein S; Furberg C
    J Am Coll Cardiol; 1987 Aug; 10(2):231-42. PubMed ID: 2439559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of beta-blockers on arrhythmias during six weeks after suspected myocardial infarction.
    Roland JM; Wilcox RG; Banks DC; Edwards B; Fentem PH; Hampton JR
    Br Med J; 1979 Sep; 2(6189):518-21. PubMed ID: 387170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality in the beta blocker heart attack trial: circumstances surrounding death.
    Peters RW; Byington R; Arensberg D; Friedman LM; Romhilt DW; Barker A; Laubach C; Wilner GW; Goldstein S
    J Chronic Dis; 1987; 40(1):75-82. PubMed ID: 3543049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous variability of ventricular arrhythmias in patients at increased risk for sudden death after acute myocardial infarction: consecutive ambulatory electrocardiographic recordings of 88 patients.
    Pratt CM; Théroux P; Slymen D; Riordan-Bennett A; Morisette D; Galloway A; Seals AA; Hallstrom A
    Am J Cardiol; 1987 Feb; 59(4):278-83. PubMed ID: 2880497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-Blocker Heart Attack Trial.
    Lampert R; Ickovics JR; Viscoli CJ; Horwitz RI; Lee FA
    Am J Cardiol; 2003 Jan; 91(2):137-42. PubMed ID: 12521623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of propranolol in postinfarction patients with mechanical or electrical complications.
    Furberg CD; Hawkins CM; Lichstein E
    Circulation; 1984 Apr; 69(4):761-5. PubMed ID: 6365352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results.
    JAMA; 1982 Mar; 247(12):1707-14. PubMed ID: 7038157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol and the morning increase in sudden cardiac death: (the beta-blocker heart attack trial experience).
    Peters RW
    Am J Cardiol; 1990 Nov; 66(16):57G-59G. PubMed ID: 2239715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-blocker heart attack trial: design, methods, and baseline results. Beta-blocker heart attack trial research group.
    Byington RP
    Control Clin Trials; 1984 Dec; 5(4):382-437. PubMed ID: 6151483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.